Illustrative pack image. Actual packaging may differ.
VARPOD CV Dry Syrup
Composition
Cefpodoxime Proxetil IP 50 mg + Potassium Clavulanate (Diluted) IP 31.25 mg
- Prescription medicine
- Available to order
Overview
VARPOD CV is a pediatric antibiotic combination that offers enhanced protection against resistant bacterial infections. Cefpodoxime, a third-generation cephalosporin, inhibits bacterial cell wall synthesis, while Clavulanate, a beta-lactamase inhibitor, extends its spectrum by neutralizing resistance enzymes produced by bacteria.
Key Benefits
- Broad-spectrum action against resistant pathogens
- Effective for pediatric respiratory and urinary infections
- Combines bactericidal and beta-lactamase inhibitory action
- Enhanced clinical efficacy and reduced chances of resistance
Indications
- Recurrent or resistant respiratory tract infections (e.g., tonsillitis, sinusitis, otitis media)
- Skin and soft tissue infections
- Pediatric urinary tract infections
- Community-acquired infections caused by beta-lactamase-producing organisms
